Related Experiment Video
Updated: Jul 8, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial
Ayelet Armon-Omer1, Aviad Levin, Zvi Hayouka
1Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Journal of Molecular Biology
|January 19, 2008
Summary
Researchers identified novel peptides that inhibit HIV-1 integrase (IN) by shifting its structure. Peptide IN-1 effectively blocked viral replication by targeting IN
Area of Science:
- Virology
- Drug Discovery
- Molecular Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) integrase (IN) is a key target for anti-HIV drug development.
- Previous work introduced
- shiftides
- as inhibitors that alter IN oligomerization.
Purpose of the Study:
- To select and characterize novel peptides that specifically bind and inhibit HIV-1 IN.
- To investigate the mechanism of inhibition by analyzing peptide effects on IN oligomerization and DNA binding.
Main Methods:
- Yeast two-hybrid system screening of a peptide aptamer library against HIV-1 IN.
- ELISA, fluorescence anisotropy, and analytical gel filtration to assess peptide binding, affinity, and oligomerization state shifts.
- In vitro enzymatic assays and cell-based HIV-1 replication assays to evaluate inhibitory activity.
Main Results:
- Five non-homologous peptides (IN-1 to IN-5) were selected for specific binding to HIV-1 IN.
- All selected peptides bound IN with similar affinities (K(d) ~10 µM).
- Only peptide IN-1 demonstrated significant inhibition of IN enzymatic activity, viral DNA binding, and HIV-1 replication, correlating with its ability to shift IN oligomerization to the inactive tetramer.
Conclusions:
- Peptide IN-1 is a potent inhibitor of HIV-1 IN activity and replication.
- The mechanism of inhibition involves shifting the IN oligomerization equilibrium towards the inactive tetramer.
- These findings validate the
- shiftide
- approach for developing novel anti-HIV therapies targeting integrase.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...